Skip to content
Meta Platforms Inc

META

Meta Platforms Inc

Meta Platforms Inc historical holders

total: 54

Giverny Capital Meta Platforms Inc transactions over time

Total transactions:
33
New positions:
1
Added:
27
Reduced:
5
Held since:
2018 Q2
Held for:
33 quarters
Latest activity:
2026 Q2
Francois Rochon has been an institutional investor in Meta Platforms Inc (META) since 2018 Q2. According to 2026 Q2 report, Francois Rochon holds 302,888 shares with a market value of roughly $170.61M representing 5.74% of their equity portfolio. The fund/company first acquired META in 2018 Q2, initially purchasing 104,672 shares. Since the initial investment, Giverny Capital has made 32 more transactions in this position.

Does Francois Rochon still hold META?

Yes, Francois Rochon continues to hold Meta Platforms Inc (META). According to their 2026 Q2 report, they maintain a position of 302,888 shares valued at approximately $170.61M, representing 5.74% of their equity portfolio.

When did Francois Rochon first invest in META?

Francois Rochon first invested in Meta Platforms Inc (META) in 2018 Q2 at the reported quarter-end price of $194.32 per share, acquiring 104,672 shares in their initial purchase.

What is Francois Rochon's average cost basis for META?

Based on historical transaction data, Francois Rochon's estimated cost basis for Meta Platforms Inc (META) is approximately $248.44 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$248.44
Weighted AVG sell price:
$388.32

META transactions history by Giverny Capital

33 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
5.74%
302,888
$563.29
$170,613,782
-1.60% (-4,933)
-0.1%
2026 Q1
6.45%
307,821
$572.13
$176,113,629
-1.80% (-5,628)
-0.11%
2025 Q4
6.90%
313,449
$660.09
$206,904,550
+0.53% (+1,639)
+0.04%
2025 Q3
7.76%
311,810
$734.38
$228,987,028
-2.22% (-7,092)
-0.18%
2025 Q2
8.07%
318,902
$738.09
$235,378,377
+1.19% (+3,758)
+0.1%
2025 Q1
6.70%
315,144
$576.36
$181,636,396
+0.02% (+49)
+0%
2024 Q4
6.74%
315,095
$585.51
$184,491,273
+1.66% (+5,153)
+0.11%
2024 Q3
6.75%
309,942
$572.44
$177,423,198
+4.11% (+12,229)
+0.27%
2024 Q2
6.34%
297,713
$504.22
$150,112,849
+0.64% (+1,893)
+0.04%
2024 Q1
5.83%
295,820
$485.58
$143,644,276
+2.74% (+7,888)
+0.16%
2023 Q4
4.79%
$353.96
+1.94% (+5,483)
2023 Q3
4.60%
$300.21
+0.98% (+2,741)
2023 Q2
4.22%
$286.98
+6.16% (+16,237)
2023 Q1
3.36%
$211.94
-2.70% (-7,315)
2022 Q4
2.01%
$120.34
+0.88% (+2,356)
2022 Q3
2.47%
$135.68
+1.76% (+4,640)
2022 Q2
2.80%
$161.25
+2.64% (+6,773)
2022 Q1
3.23%
$222.36
+3.51% (+8,706)
2021 Q4
4.46%
$336.35
+0.06% (+153)
2021 Q3
5.02%
$339.39
+5.92% (+13,863)
2021 Q2
4.95%
$347.71
+1.16% (+2,680)
2021 Q1
4.56%
$294.53
+5.48% (+12,025)
2020 Q4
4.60%
$273.16
+3.75% (+7,929)
2020 Q3
5.08%
$261.90
+0.43% (+910)
2020 Q2
4.76%
$227.07
+24.40% (+41,336)
2020 Q1
3.60%
$166.80
-7.54% (-13,821)
2019 Q4
3.40%
$205.25
+3.55% (+6,284)
2019 Q3
3.14%
$178.08
+2.10% (+3,636)
2019 Q2
3.38%
$193.00
+5.31% (+8,743)
2019 Q1
3.15%
$166.69
+40.82% (+47,703)
2018 Q4
2.02%
$131.09
+2.87% (+3,261)
2018 Q3
2.12%
$164.46
+8.54% (+8,937)
2018 Q2
2.65%
$194.32
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.